A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants with Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519157-10-00

Acronym

M25-433

Enrollment

Registered

2025-08-28

Start date

2025-11-24

Completion date

Unknown

Last updated

2025-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren's disease, Systemic Lupus Erythematosus

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026